Sign Up to like & get
recommendations!
0
Published in 2023 at "Antibodies"
DOI: 10.3390/antib12010014
Abstract: The current diagnosis of diffuse glioma involves isocitrate dehydrogenase (IDH) mutation testing. Most IDH mutant gliomas carry a G-to-A mutation at IDH1 position 395, resulting in the R132H mutant. R132H immunohistochemistry (IHC), therefore, is used…
read more here.
Keywords:
r132h mutant;
idh1 r132h;
mutation;
mrq ... See more keywords